The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this approach offers a more convenient way to provide https://ammarftmh926667.ssnblog.com/39639678/glp-1-patches-a-novel-approach-to-glucose-management